AffiAB® Anti-Hu CD135 FITC [BV10A4]

https://www.affiab.com/web/image/product.template/109930/image_1920?unique=d31c23b
(0 review)

CAT# AFG-EXB-1262
Size: 0.1 mg

239.00 239.0 USD 239.00

239.00

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Overview

CD135 / FLT3, also known as FLK2 or STK-1 is a receptor tyrosine kinase that plays important roles in hematopoiesis. After binding of Flt3 ligand (FL), CD135 homodimerizes and stimulates proliferation, differentiation and protects the cell from apoptosis. The loss of CD90 and gain of CD135 expression marks the loss of self-renewal in hematopoietic stem cell population. Detectable CD135 expression appears first at low levels on the surface of primitive multilineage progenitor cells and disappears during defined stages of B-cell development, but is upregulated and maintained during maturation of monocytes. CD135 is also expressed on thymocytes, dendritic cell progenitors and on mature dendritic cells, as well as on various malignant hematopoietic cells.


Specificity:

The mouse monoclonal antibody BV10A4 (BV10) reacts with an extracellular epitope of CD135 (FLT3, FLK2, STK-1), a 130-160 kDa type I transmembrane receptor tyrosine kinase that is involved in early steps of hematopoiesis.

Antigen

CD135

Clone

BV10A4

Species Reactivity

Human

Negative Species

Mouse

Isotype

Mouse IgG1

Immunogen

BV-173 leukemic cell line

Application

FC (QC tested)

Regulatory status

RUO

Concentration

N/A

Format

FITC

Storage / Stability

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Storage Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide